Product Information
CHLORDIAZEPOXIDE-CLIDINIUM CAP is a generic product labeled by Aurobindo Pharma Limited, priced at $0.2692 per EA under NDC 59651052401. Its NADAC has been published 96 times since Aug 28, 2024.
Strength
5; 2.5 mg/1; mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651052401
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA216419On Market Since
9/14/2023
Pharmacological Classes
Price Statistics
The NADAC for CHLORDIAZEPOXIDE-CLIDINIUM CAP has been published 96 times since Aug 28, 2024, and over the history we have for it it has declined 37.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2692 per EA |
|---|---|
| All-time high | $0.5272 (Oct 16, 2024) |
| All-time low | $0.2405 (Mar 18, 2026) |
| 52-week high | $0.3051 |
| 52-week low | $0.2405 |
| Median price | $0.2859 |
| Average price | $0.3074 |
| Largest weekly change | -26.2% (Nov 20, 2024) |
| Weeks tracked | 96 |
| Tracking since | Aug 28, 2024 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CHLORDIAZEPOXIDE-CLIDINIUM CAP?
The current National Average Drug Acquisition Cost (NADAC) for CHLORDIAZEPOXIDE-CLIDINIUM CAP, manufactured by Aurobindo Pharma Limited, is $0.2692 per EA (NDC 59651052401), effective Jun 24, 2026.
How has the price of CHLORDIAZEPOXIDE-CLIDINIUM CAP changed over time?
Over the history we have for it, the NADAC for CHLORDIAZEPOXIDE-CLIDINIUM CAP has declined 37.4%. It has been tracked across 96 weekly CMS publications since Aug 28, 2024.
What are the highest and lowest recorded NADAC prices for CHLORDIAZEPOXIDE-CLIDINIUM CAP?
Since Aug 28, 2024, the NADAC for CHLORDIAZEPOXIDE-CLIDINIUM CAP has ranged from a low of $0.2405 (Mar 18, 2026) to a high of $0.5272 (Oct 16, 2024), with a median of $0.2859 per EA.
Are there cheaper alternatives to CHLORDIAZEPOXIDE-CLIDINIUM CAP?
4 NADAC-published products share the same active ingredient, strength, and dosage form as CHLORDIAZEPOXIDE-CLIDINIUM CAP, but none are currently priced below it.
Who manufactures CHLORDIAZEPOXIDE-CLIDINIUM CAP?
CHLORDIAZEPOXIDE-CLIDINIUM CAP (NDC 59651052401) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification